Hologic (NASDAQ:HOLX) CFO Glenn Muir unloaded 28,000 shares of Hologic stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $20.45, for a total transaction of $572,600.00. Following the transaction, the chief financial officer now directly owns 825,891 shares of the company’s stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Hologic (NASDAQ:HOLX) in a research note to investors on Wednesday. They now have a $22.00 price target on the stock. Separately, analysts at TheStreet downgraded shares of Hologic (NASDAQ:HOLX) to a “hold” rating in a research note to investors on Tuesday. Finally, analysts at Raymond James downgraded shares of Hologic (NASDAQ:HOLX) from an “outperform” rating to a “market perform” rating in a research note to investors on Wednesday, September 11th. They now have a $23.00 price target on the stock.
One research analyst has rated the stock with a sell rating, six have assigned a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $23.85.
Hologic (NASDAQ:HOLX) traded down 1.29% during mid-day trading on Wednesday, hitting $20.295. 3,304,240 shares of the company’s stock traded hands. Hologic has a 52-week low of $18.46 and a 52-week high of $23.96. The stock has a 50-day moving average of $21.98 and a 200-day moving average of $21.29. The company’s market cap is $5.489 billion.
Hologic (NASDAQ:HOLX) last announced its earnings results on Monday, August 5th. The company reported $0.38 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.37 by $0.01. The company had revenue of $626.10 million for the quarter, compared to the consensus estimate of $627.05 million. During the same quarter in the prior year, the company posted $0.35 earnings per share. The company’s quarterly revenue was up 33.2% on a year-over-year basis. Analysts expect that Hologic will post $1.48 EPS for the current fiscal year.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.